Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pharmacovigilance and drug safety in Calabria (Italy): 2012 adverse events analysis.
Giofrè C, Scicchitano F, Palleria C, Mazzitello C, Ciriaco M, Gallelli L, Paletta L, Marrazzo G, Leporini C, Ventrice P, Carbone C, Saullo F, Rende P, Menniti M, Mumoli L, Chimirri S, Patanè M, Esposito S, Cilurzo F, Staltari O, Russo E, De Sarro G; UNIVIGIL CZ Group. Giofrè C, et al. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S55-60. doi: 10.4103/0976-500X.120963. J Pharmacol Pharmacother. 2013. PMID: 24347984 Free PMC article.
Pharmacovigilance and drug safety 2011 in Calabria (Italy): Adverse events analysis.
Scicchitano F, Giofrè C, Palleria C, Mazzitello C, Ciriaco M, Gallelli L, Paletta L, Marrazzo G, De Fazio S, Menniti M, Curia R, Arena C, Chimirri S, Patanè M, Esposito S, Cilurzo F, Staltari O, Russo E, De Sarro G. Scicchitano F, et al. Among authors: giofre c. J Res Med Sci. 2012 Sep;17(9):872-5. J Res Med Sci. 2012. PMID: 23826016 Free PMC article.
Informatics applied to pharmacovigilance: Future perspectives.
Menniti M, Menniti A, Patanè M, Esposito S, Giofrè C, Aiello R, Russo E. Menniti M, et al. Among authors: giofre c. J Pharmacol Pharmacother. 2013 Dec;4(Suppl 1):S43-6. doi: 10.4103/0976-500X.120950. J Pharmacol Pharmacother. 2013. PMID: 24347981 Free PMC article.
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study.
Dattola A, Bernardini N, Svara F, Balato A, Caldarola G, D'Amico D, De Simone C, Di Brizzi EV, Esposito M, Giofrè C, Giordano D, Guarneri C, Loconsole F, Lora V, Moretta G, Orsini D, Persechino S, Potenza C, Ragonesi S, Pellacani G, Peris K, Fargnoli MC, Richetta AG. Dattola A, et al. Among authors: giofre c. J Dermatolog Treat. 2024 Dec;35(1):2420825. doi: 10.1080/09546634.2024.2420825. Epub 2024 Oct 27. J Dermatolog Treat. 2024. PMID: 39462515 Free article.
A prospective Real-Life Multicenter Study of Tildrakizumab 200 mg in Patients with Moderate-Severe Psoriasis: Who is the Ideal Patient?
Di Brizzi EV, Caccavale S, Di Caprio R, Cusano F, De Pasquale R, Falcomatà V, Foti C, Giofrè C, Gubinelli E, Mazzocchetti G, Nicolini M, Palazzo G, Pescitelli L, Puca RV, Sarno O, Balato A. Di Brizzi EV, et al. Among authors: giofre c. Dermatol Pract Concept. 2024 Oct 30;14(4):e2024284. doi: 10.5826/dpc.1404a284. Dermatol Pract Concept. 2024. PMID: 39453881 Free PMC article.
23 results